Cash flow West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:03 11/04/2026 am IST			5-day change	1st Jan Change
256.55 ^USD	-0.77%		+0.69%	-6.76%

31/03	West Pharmaceutical Services, Inc. Expands Dublin Facility to Support High-Volume Injectable Therapies	CI
31/03	West Pharmaceutical Reports Dublin Facility Expansion	MT

935ec59d878ebdbd0c0d677.dmWptgu3O9YhPjvGye2R9p_bQJWsyvYq4rD6QjyC7Zk.GBXnhjzHCLpWD3e3k732rPG2NfjYjpQYssaPCFLsmf4eSPbiTtBPr3ETfg

Published financial data: WEST PHARMACEUTICAL SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	283.16Cr	288.69Cr	294.98Cr	289.32Cr	307.41Cr
Total Revenues	283.16Cr	288.69Cr	294.98Cr	289.32Cr	307.41Cr
Cost of Goods Sold, Total	165.58Cr	175.07Cr	181.98Cr	189.47Cr	197.01Cr
Gross Profit	117.58Cr	113.62Cr	113Cr	100Cr	110.4Cr
Selling General & Admin Expenses, Total	36Cr	32Cr	35Cr	33Cr	39Cr
R&D Expenses	5.28Cr	5.85Cr	6.84Cr	6.91Cr	7.43Cr
Other Operating Expenses	-	-21L	13L	9L	13L
Other Operating Expenses, Total	41Cr	37Cr	42Cr	40Cr	47Cr
Operating Income	76Cr	76Cr	71Cr	59Cr	64Cr
Interest Expense, Total	-82L	-79L	-90L	-30L	-5L
Interest And Investment Income	10L	51L	2.8Cr	1.96Cr	1.75Cr
Net Interest Expenses	-72L	-28L	1.9Cr	1.66Cr	1.7Cr
Income (Loss) On Equity Invest.	2.01Cr	2.07Cr	1.77Cr	1.47Cr	1.44Cr
Currency Exchange Gains (Loss)	14L	41L	-94L	-1.02Cr	-84L
EBT, Excl. Unusual Items	78Cr	79Cr	73Cr	61Cr	66Cr
Restructuring Charges	-22L	-2.38Cr	20L	-21L	-2.95Cr
Gain (Loss) On Sale Of Investments	-43L	-35L	-43L	-3L	-45L
Gain (Loss) On Sale Of Assets	-	-	-1.16Cr	-	-
Asset Writedown	-13L	-27L	-53L	-70L	-37L
Legal Settlements	-	-	38L	-	-
Other Unusual Items	-15L	-5.52Cr	-24L	-51L	-87L
EBT, Incl. Unusual Items	77Cr	70Cr	72Cr	60Cr	62Cr
Income Tax Expense	11Cr	11Cr	12Cr	11Cr	12Cr
Earnings From Continuing Operations	66Cr	59Cr	59Cr	49Cr	49Cr
Net Income to Company	66Cr	59Cr	59Cr	49Cr	49Cr
Net Income - (IS)	66Cr	59Cr	59Cr	49Cr	49Cr
Net Income to Common Incl Extra Items	66Cr	59Cr	59Cr	49Cr	49Cr
Net Income to Common Excl. Extra Items	66Cr	59Cr	59Cr	49Cr	49Cr
Per Share Items
Net EPS - Basic	8.9	7.88	7.99	6.75	6.83
Basic EPS - Continuing Operations	8.9	7.88	7.99	6.75	6.83
Basic Weighted Average Shares Outstanding	7.44Cr	7.44Cr	7.43Cr	7.3Cr	7.23Cr
Net EPS - Diluted	8.67	7.73	7.88	6.69	6.79
Diluted EPS - Continuing Operations	8.67	7.73	7.88	6.69	6.79
Diluted Weighted Average Shares Outstanding	7.63Cr	7.58Cr	7.53Cr	7.37Cr	7.27Cr
Normalized Basic EPS	6.54	6.6	6.17	5.26	5.72
Normalized Diluted EPS	6.38	6.48	6.09	5.21	5.69
Dividend Per Share	0.69	0.73	0.77	0.81	0.85
Payout Ratio	7.72	9.23	9.61	12	12.4
Supplemental Items
EBITDA	89Cr	88Cr	84Cr	75Cr	81Cr
EBITA	77Cr	77Cr	71Cr	60Cr	64Cr
EBIT	76Cr	76Cr	71Cr	59Cr	64Cr
EBITDAR	91Cr	91Cr	88Cr	78Cr	85Cr
Effective Tax Rate - (Ratio)	13.94	16.37	17.09	17.91	19.76
Current Domestic Taxes	7.57Cr	8.41Cr	2.6Cr	3.19Cr	5.23Cr
Current Foreign Taxes	7.44Cr	6.14Cr	5.88Cr	7.91Cr	8.3Cr
Total Current Taxes	15Cr	15Cr	8.48Cr	11Cr	14Cr
Deferred Domestic Taxes	73L	-2.03Cr	-1.16Cr	-1.83Cr	-1.4Cr
Deferred Foreign Taxes	-5.02Cr	-1.05Cr	4.91Cr	1.48Cr	3L
Total Deferred Taxes	-4.29Cr	-3.08Cr	3.75Cr	-35L	-1.37Cr
Normalized Net Income	49Cr	49Cr	46Cr	38Cr	41Cr
Interest Capitalized	20L	37L	58L	1.32Cr	1.46Cr
Interest on Long-Term Debt	1.02Cr	1.16Cr	1.48Cr	1.62Cr	1.51Cr
Non-Cash Pension Expense	-20L	5.26Cr	22L	24L	21L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	5.28Cr	5.85Cr	6.84Cr	6.91Cr	7.43Cr
Net Rental Expense, Total	1.88Cr	2.36Cr	3.19Cr	3.57Cr	4.01Cr
Imputed Operating Lease Interest Expense	46.73L	68.1L	1.2Cr	1.51Cr	1.53Cr
Imputed Operating Lease Depreciation	1.41Cr	1.68Cr	1.99Cr	2.06Cr	2.48Cr
Stock-Based Comp., SG&A Exp. (Total)	3.75Cr	2.37Cr	2.33Cr	1.87Cr	2.38Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	3.75Cr	2.37Cr	2.33Cr	1.87Cr	2.38Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	76Cr	89Cr	85Cr	48Cr	79Cr
Total Cash And Short Term Investments	76Cr	89Cr	85Cr	48Cr	79Cr
Accounts Receivable, Total	49Cr	52Cr	53Cr	58Cr	59Cr
Total Receivables	49Cr	52Cr	53Cr	58Cr	59Cr
Inventory	38Cr	41Cr	43Cr	38Cr	44Cr
Other Current Assets, Total	11Cr	8.67Cr	11Cr	10Cr	16Cr
Total Current Assets	174.2Cr	191.95Cr	193.64Cr	153.81Cr	197.82Cr
Gross Property Plant And Equipment	228.43Cr	249.1Cr	283.72Cr	312Cr	337.51Cr
Accumulated Depreciation	-115.75Cr	-122.83Cr	-132.47Cr	-140.42Cr	-149.7Cr
Net Property Plant And Equipment	112.68Cr	126.27Cr	151.25Cr	171.58Cr	187.81Cr
Long-term Investments	21Cr	20Cr	21Cr	20Cr	21Cr
Goodwill	11Cr	11Cr	11Cr	11Cr	11Cr
Other Intangibles, Total	2.3Cr	1.84Cr	1.51Cr	1.08Cr	77L
Accounts Receivable Long-Term	1.46Cr	-	-	-	-
Deferred Tax Assets Long-Term	4.85Cr	6.56Cr	2.57Cr	2.6Cr	3.84Cr
Deferred Charges Long-Term	1L	-	-	-	-
Other Long-Term Assets, Total	4.12Cr	3.84Cr	2.13Cr	4.46Cr	4.54Cr
Total Assets	331.38Cr	361.68Cr	382.95Cr	364.34Cr	427Cr
Liabilities
Accounts Payable, Total	23Cr	22Cr	24Cr	24Cr	25Cr
Accrued Expenses, Total	19Cr	14Cr	16Cr	14Cr	21Cr
Current Portion of Long-Term Debt	4.42Cr	22L	13Cr	-	-
Current Portion of Leases	93L	1.6Cr	1.77Cr	1.88Cr	2.42Cr
Current Income Taxes Payable	2.63Cr	2.48Cr	1.66Cr	3.15Cr	2.81Cr
Unearned Revenue Current, Total	4.87Cr	5.73Cr	4.17Cr	4.96Cr	5.19Cr
Other Current Liabilities	4.73Cr	6.01Cr	5.81Cr	7.32Cr	8.24Cr
Total Current Liabilities	59Cr	52Cr	67Cr	55Cr	65Cr
Long-Term Debt	21Cr	21Cr	7.28Cr	20Cr	20Cr
Long-Term Leases	6.3Cr	9.3Cr	8.45Cr	8.39Cr	9.92Cr
Unearned Revenue Non Current	30L	21L	1.22Cr	36L	18L
Pension & Other Post Retirement Benefits	4.05Cr	2.82Cr	2.96Cr	2.82Cr	2.9Cr
Deferred Tax Liability Non Current	49L	1.43Cr	1.27Cr	2.05Cr	2.3Cr
Other Non Current Liabilities	6.41Cr	6.86Cr	6.49Cr	7.19Cr	8.33Cr
Total Liabilities	98Cr	93Cr	95Cr	96Cr	109.4Cr
Common Stock, Total	1.88Cr	1.88Cr	1.88Cr	1.88Cr	1.88Cr
Additional Paid In Capital	25Cr	23Cr	12Cr	2.21Cr	-
Retained Earnings	245.67Cr	298.78Cr	352.34Cr	395.66Cr	437.49Cr
Treasury Stock	-23Cr	-37Cr	-64Cr	-105.71Cr	-111.22Cr
Comprehensive Income and Other	-16Cr	-18Cr	-14Cr	-26Cr	-11Cr
Total Common Equity	233.54Cr	268.49Cr	288.1Cr	268.23Cr	317.6Cr
Total Equity	233.54Cr	268.49Cr	288.1Cr	268.23Cr	317.6Cr
Total Liabilities And Equity	331.38Cr	361.68Cr	382.95Cr	364.34Cr	427Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.43Cr	7.41Cr	7.33Cr	7.23Cr	7.2Cr
ECS Total Common Shares Outstanding	7.42Cr	7.41Cr	7.35Cr	7.23Cr	7.2Cr
Book Value / Share	31.47	36.23	39.2	37.1	44.11
Tangible Book Value	220.25Cr	255.92Cr	275.74Cr	256.55Cr	305.84Cr
Tangible Book Value Per Share	29.68	34.54	37.52	35.48	42.48
Total Debt	33Cr	32Cr	31Cr	31Cr	33Cr
Net Debt	-44Cr	-58Cr	-54Cr	-18Cr	-47Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.06Cr	2.61Cr	2.52Cr	2.4Cr	2.38Cr
Debt Equivalent Oper. Leases	15Cr	19Cr	26Cr	29Cr	32Cr
Equity Method Investments, Total	21Cr	20Cr	21Cr	20Cr	21Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	15Cr	17Cr	17Cr	17Cr	16Cr
Inventories - Work In Process, Total	6.35Cr	7.9Cr	8.73Cr	6.52Cr	10Cr
Inventories - Finished Goods, Total	16Cr	17Cr	18Cr	14Cr	18Cr
Land - (BS)	2.93Cr	2.9Cr	3.37Cr	2.79Cr	2.92Cr
Buildings, Total	64Cr	66Cr	77Cr	92Cr	118.07Cr
Machinery, Total	129.82Cr	138.81Cr	151.76Cr	163.1Cr	175.68Cr
Full Time Employees	10.06T	10.7T	10.6T	10.6T	10.8T
Part Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	4L	2L	8L	8L	14L
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	66Cr	59Cr	59Cr	49Cr	49Cr
Depreciation & Amortization - CF	12Cr	12Cr	13Cr	15Cr	17Cr
Amortization of Goodwill and Intangible Assets - (CF)	54L	37L	36L	36L	28L
Depreciation & Amortization, Total	12Cr	12Cr	14Cr	16Cr	17Cr
(Gain) Loss From Sale Of Asset	-	-	1.16Cr	-	-
Asset Writedown & Restructuring Costs	13L	1.8Cr	96L	73L	1.71Cr
(Income) Loss On Equity Investments - (CF)	-1.74Cr	-1.81Cr	-1.43Cr	-1.34Cr	-1.05Cr
Stock-Based Compensation (CF)	3.75Cr	2.37Cr	2.33Cr	1.87Cr	2.38Cr
Other Operating Activities, Total	-2.77Cr	54L	3.6Cr	-1.02Cr	-2.05Cr
Change In Accounts Receivable	-12Cr	-3.56Cr	40L	-5.88Cr	69L
Change In Inventories	-8.65Cr	-4.98Cr	-1.35Cr	4.2Cr	-6.28Cr
Change In Accounts Payable	1.68Cr	-28L	44L	29L	1.79Cr
Change in Other Net Operating Assets	-6L	7.67Cr	-1.53Cr	1.68Cr	12Cr
Cash from Operations	58Cr	72Cr	78Cr	65Cr	75Cr
Capital Expenditure	-25Cr	-28Cr	-36Cr	-38Cr	-29Cr
Cash Acquisitions	-22L	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	25L	-36L	-67L	-17L	-
Cash from Investing	-25Cr	-29Cr	-37Cr	-38Cr	-29Cr
Long-Term Debt Issued, Total	-	-	-	16Cr	-
Total Debt Issued	-	-	-	16Cr	-
Long-Term Debt Repaid, Total	-22L	-4.43Cr	-23L	-19Cr	-11L
Total Debt Repaid	-22L	-4.43Cr	-23L	-19Cr	-11L
Issuance of Common Stock	3.71Cr	2.82Cr	5.1Cr	3.27Cr	1.82Cr
Repurchase of Common Stock	-15Cr	-22Cr	-45Cr	-57Cr	-14Cr
Common Dividends Paid	-5.11Cr	-5.41Cr	-5.7Cr	-5.91Cr	-6.12Cr
Common & Preferred Stock Dividends Paid	-5.11Cr	-5.41Cr	-5.7Cr	-5.91Cr	-6.12Cr
Other Financing Activities, Total	-	-12L	-1L	-20L	-42L
Cash from Financing	-17Cr	-29Cr	-46Cr	-62Cr	-19Cr
Foreign Exchange Rate Adjustments	-1.57Cr	-1.05Cr	1.14Cr	-2.14Cr	2.29Cr
Net Change in Cash	15Cr	13Cr	-4.04Cr	-37Cr	31Cr
Supplemental Items
Cash Interest Paid	80L	66L	60L	5L	3L
Cash Income Tax Paid (Refund)	17Cr	11Cr	9.08Cr	7.14Cr	13Cr
Levered Free Cash Flow	21Cr	25Cr	20Cr	21Cr	27Cr
Unlevered Free Cash Flow	21Cr	25Cr	20Cr	21Cr	27Cr
Change In Net Working Capital	17Cr	8.56Cr	3.8Cr	-4.05Cr	3.43Cr
Net Debt Issued / Repaid	-22L	-4.43Cr	-23L	-2.76Cr	-11L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	15.64	13.78	11.85	9.93	10.09
Return on Total Capital	19.7	16.86	14.25	12.01	12.3
Return On Equity %	31.59	23.34	21.32	17.71	16.85
Return on Common Equity	31.59	23.34	21.32	17.71	16.85
Margin Analysis
Gross Profit Margin %	41.52	39.36	38.31	34.51	35.91
SG&A Margin	12.68	10.95	12	11.58	12.68
EBITDA Margin %	31.3	30.63	28.6	25.89	26.35
EBITA Margin %	27.17	26.59	24.06	20.64	20.87
EBIT Margin %	26.98	26.46	23.94	20.52	20.78
Income From Continuing Operations Margin %	23.37	20.3	20.12	17.03	16.06
Net Income Margin %	23.37	20.3	20.12	17.03	16.06
Net Avail. For Common Margin %	23.37	20.3	20.12	17.03	16.06
Normalized Net Income Margin	17.18	17.01	15.54	13.28	13.45
Levered Free Cash Flow Margin	7.32	8.54	6.66	7.15	8.91
Unlevered Free Cash Flow Margin	7.5	8.71	6.85	7.21	8.92
Asset Turnover
Asset Turnover	0.93	0.83	0.79	0.77	0.78
Fixed Assets Turnover	2.65	2.42	2.13	1.79	1.71
Receivables Turnover (Average Receivables)	6.48	5.62	5.58	5.22	5.29
Inventory Turnover (Average Inventory)	4.73	4.41	4.28	4.67	4.8
Short Term Liquidity
Current Ratio	2.93	3.7	2.88	2.79	3.02
Quick Ratio	2.11	2.73	2.07	1.93	2.1
Operating Cash Flow to Current Liabilities	0.98	1.39	1.16	1.19	1.15
Days Sales Outstanding (Average Receivables)	56.35	64.94	65.41	70.17	68.99
Days Outstanding Inventory (Average Inventory)	77.12	82.69	85.19	78.4	76.04
Average Days Payable Outstanding	47.44	45.71	45.41	47.99	44.17
Cash Conversion Cycle (Average Days)	86.03	101.92	105.19	100.58	100.86
Long Term Solvency
Total Debt/Equity	13.93	11.84	10.73	11.38	10.27
Total Debt / Total Capital	12.23	10.59	9.69	10.22	9.31
LT Debt/Equity	11.64	11.16	5.46	10.68	9.51
Long-Term Debt / Total Capital	10.22	9.98	4.93	9.59	8.62
Total Liabilities / Total Assets	29.52	25.77	24.77	26.38	25.62
EBIT / Interest Expense	93.17	96.68	78.47	197.87	1.28T
EBITDA / Interest Expense	110.38	114.94	97.27	261.57	1.7T
(EBITDA - Capex) / Interest Expense	79.48	78.91	57.04	135.9	1.13T
Total Debt / EBITDA	0.36	0.35	0.35	0.39	0.38
Net Debt / EBITDA	-0.48	-0.63	-0.62	-0.23	-0.55
Total Debt / (EBITDA - Capex)	0.5	0.51	0.6	0.75	0.58
Net Debt / (EBITDA - Capex)	-0.67	-0.92	-1.06	-0.44	-0.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	31.89	1.95	2.18	-1.92	6.25
Gross Profit, 1 Yr. Growth %	53.14	-3.52	-0.55	-11.64	10.57
EBITDA, 1 Yr. Growth %	67.48	-0.53	-4.62	-11.2	8.16
EBITA, 1 Yr. Growth %	81.25	-0.61	-7.52	-15.86	7.42
EBIT, 1 Yr. Growth %	81.86	-0.39	-7.54	-15.94	7.6
Earnings From Cont. Operations, 1 Yr. Growth %	91.16	-11.47	1.28	-16.97	0.2
Net Income, 1 Yr. Growth %	91.16	-11.47	1.28	-16.97	0.2
Normalized Net Income, 1 Yr. Growth %	80.08	0.6	-6.66	-16.2	7.65
Diluted EPS Before Extra, 1 Yr. Growth %	89.72	-10.84	1.94	-15.1	1.49
Accounts Receivable, 1 Yr. Growth %	26.91	3.99	1.87	7.93	1.82
Inventory, 1 Yr. Growth %	17.77	9.62	4.8	-13.27	17.75
Net Property, Plant and Equip., 1 Yr. Growth %	11.4	12.06	19.78	13.44	9.46
Total Assets, 1 Yr. Growth %	18.61	9.14	5.88	-4.86	17.2
Tangible Book Value, 1 Yr. Growth %	28.58	16.2	7.74	-6.96	19.21
Common Equity, 1 Yr. Growth %	25.93	14.97	7.3	-6.9	18.41
Cash From Operations, 1 Yr. Growth %	23.6	23.97	7.25	-15.85	15.52
Capital Expenditures, 1 Yr. Growth %	45.3	12.31	27.2	4.14	-24.16
Levered Free Cash Flow, 1 Yr. Growth %	-16.74	18	-20.36	5.28	32.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-16.4	17.48	-19.68	3.28	31.44
Dividend Per Share, 1 Yr. Growth %	6.15	5.8	5.48	5.19	4.94
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.06	15.96	2.07	0.11	2.09
Gross Profit, 2 Yr. CAGR %	39.33	21.65	-2.05	-6.26	-1.16
EBITDA, 2 Yr. CAGR %	48.97	28.97	-2.7	-7.97	-2
EBITA, 2 Yr. CAGR %	60.31	34.07	-4.24	-11.79	-4.93
EBIT, 2 Yr. CAGR %	60.66	34.44	-4.15	-11.84	-4.9
Earnings From Cont. Operations, 2 Yr. CAGR %	65.47	30.09	-5.31	-8.3	-8.79
Net Income, 2 Yr. CAGR %	65.47	30.09	-5.31	-8.3	-8.79
Normalized Net Income, 2 Yr. CAGR %	59.8	34.45	-3.21	-11.55	-5.02
Diluted EPS Before Extra, 2 Yr. CAGR %	64.35	30.06	-4.66	-6.97	-7.17
Accounts Receivable, 2 Yr. CAGR %	23.75	16.58	2.93	4.86	4.83
Inventory, 2 Yr. CAGR %	26.71	13.62	7.18	-4.67	1.05
Net Property, Plant and Equip., 2 Yr. CAGR %	11.31	11.73	15.86	16.57	11.43
Total Assets, 2 Yr. CAGR %	18.97	13.78	7.5	0.37	5.59
Tangible Book Value, 2 Yr. CAGR %	23.86	22.23	11.89	0.12	5.32
Common Equity, 2 Yr. CAGR %	21.84	20.32	11.07	-0.05	5
Cash From Operations, 2 Yr. CAGR %	26.11	23.79	15.31	-5	-1.41
Capital Expenditures, 2 Yr. CAGR %	41.59	27.75	19.52	15.09	-11.13
Levered Free Cash Flow, 2 Yr. CAGR %	12.19	-0.77	-3.32	-8.43	18.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	11.78	-0.8	-3.12	-8.92	16.51
Dividend Per Share, 2 Yr. CAGR %	6.36	5.98	5.64	5.34	5.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.14	16.2	11.17	0.72	2.12
Gross Profit, 3 Yr. CAGR %	29.18	23.33	13.75	-5.35	-0.95
EBITDA, 3 Yr. CAGR %	35.62	30.34	16.63	-5.62	-2.88
EBITA, 3 Yr. CAGR %	44.77	36.86	18.46	-8.28	-5.8
EBIT, 3 Yr. CAGR %	44.94	37.16	18.67	-8.25	-5.79
Earnings From Cont. Operations, 3 Yr. CAGR %	47.34	34.33	19.68	-9.37	-5.55
Net Income, 3 Yr. CAGR %	47.34	34.33	19.68	-9.37	-5.55
Normalized Net Income, 3 Yr. CAGR %	44.55	37.12	19.05	-7.75	-5.57
Diluted EPS Before Extra, 3 Yr. CAGR %	46.81	34.04	19.91	-8.28	-4.23
Accounts Receivable, 3 Yr. CAGR %	19.27	17.93	11.46	4.57	3.84
Inventory, 3 Yr. CAGR %	20.83	20.73	10.6	-0.12	2.29
Net Property, Plant and Equip., 3 Yr. CAGR %	11.09	11.56	14.35	15.05	14.15
Total Assets, 3 Yr. CAGR %	18.75	15.6	11.08	3.21	5.69
Tangible Book Value, 3 Yr. CAGR %	20.14	21.25	17.2	5.22	6.12
Common Equity, 3 Yr. CAGR %	18.7	19.5	15.82	4.72	5.76
Cash From Operations, 3 Yr. CAGR %	26.48	25.39	18.01	3.81	1.4
Capital Expenditures, 3 Yr. CAGR %	34.26	31.07	27.56	14.16	0.15
Levered Free Cash Flow, 3 Yr. CAGR %	19.61	14.42	-7.79	-0.53	3.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.9	13.96	-7.54	-1.03	2.92
Dividend Per Share, 3 Yr. CAGR %	6.58	6.17	5.81	5.49	5.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.41	12.54	11.43	9.48	7.44
Gross Profit, 5 Yr. CAGR %	18.58	17.24	15.68	10.51	7.53
EBITDA, 5 Yr. CAGR %	22.63	21.36	18.88	13.4	8.79
EBITA, 5 Yr. CAGR %	27.15	26.01	22.86	14.81	8.48
EBIT, 5 Yr. CAGR %	27.26	26.14	22.99	14.93	8.61
Earnings From Cont. Operations, 5 Yr. CAGR %	35.74	31.2	23.46	15.31	7.36
Net Income, 5 Yr. CAGR %	35.74	31.2	23.46	15.31	7.36
Normalized Net Income, 5 Yr. CAGR %	27.6	26.57	23.27	15.06	8.77
Diluted EPS Before Extra, 5 Yr. CAGR %	35.33	31.18	23.53	15.82	8.24
Accounts Receivable, 5 Yr. CAGR %	19.52	15.64	13.11	12.52	8.76
Inventory, 5 Yr. CAGR %	13.68	14.02	15.17	9.85	6.68
Net Property, Plant and Equip., 5 Yr. CAGR %	7.68	8.11	12.97	13.54	13.18
Total Assets, 5 Yr. CAGR %	14.06	14.19	14.12	9.25	8.85
Tangible Book Value, 5 Yr. CAGR %	17.31	17.34	16.77	12.31	12.29
Common Equity, 5 Yr. CAGR %	15.88	15.97	15.59	11.26	11.36
Cash From Operations, 5 Yr. CAGR %	21.63	22.42	21.89	12.22	9.82
Capital Expenditures, 5 Yr. CAGR %	8.29	16.82	28.16	24.43	10.39
Levered Free Cash Flow, 5 Yr. CAGR %	45.29	20.06	10.16	4.66	1.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	41.78	19.38	9.84	4.19	1.42
Dividend Per Share, 5 Yr. CAGR %	7.09	6.61	6.2	5.84	5.51